The United Kingdom is witnessing a significant surge in interest surrounding mind-altering substances. Beyond the well-established use of psilocybin and LSD, investigators and explorers are increasingly focused on less-charted areas, particularly copyright and the nascent cannabinoid, CBG compound. This expanding movement encompasses therapeutic re